Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study
Haematologica
.
2021 Feb 1;106(2):622-625.
doi: 10.3324/haematol.2020.250522.
Authors
Bruno Fattizzo
1
,
Marc Michel
2
,
Anna Zaninoni
1
,
Juri Giannotta
1
,
Stephanie Guillet
3
,
Henrik Frederiksen
4
,
Josephine M I Vos
5
,
Francesca R Mauro
6
,
Bernd Jilma
7
,
Andrea Patriarca
8
,
Francesco Zaja
9
,
Anita Hill
10
,
Sigbiørn Berentsen
11
,
Wilma Barcellini
1
Affiliations
1
Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano and University of Milan, Milan, Italy.
2
Department of Internal Medecine, Henri Mondor University Hospital, Assistance Pub Hôpitaux de Paris,Creteil, France.
3
Department of Internal Medecine, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Creteil, France.
4
Department of Haematology, Odense University Hospital, Denmark.
5
Amsterdam UMC, location AMC, Department of Hematology, Amsterdam, The Netherlands.
6
Haematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
7
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
8
UO Ematologia, AOU Maggiore della Carità, Novara, Italy.
9
S.C. Ematologia, Azienda Sanitaria Universitaria Integrata, Trieste, ITA.
10
Haematology, Leeds Teaching Hospitals, Leeds, United Kingdom.
11
Department of Research and Innovation, Haugesund Hospital, Haugesund, Norway.
PMID:
32354865
PMCID:
PMC7849557
DOI:
10.3324/haematol.2020.250522
No abstract available
Publication types
Letter
Multicenter Study
MeSH terms
Anemia, Hemolytic*
Anemia, Hemolytic, Autoimmune* / drug therapy
Erythropoietin*
Humans
Recombinant Proteins
Substances
Recombinant Proteins
Erythropoietin